{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-044287","form_type":"8-K","ticker":null,"cik":"0001173281","company_name":"NeuBase Therapeutics, Inc.","filed_at":"2024-04-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.527356+00:00","generated_at":"2026-06-04T01:41:11.548535+00:00","sec_items":["3.01","8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NeuBase receives Nasdaq non-compliance notice for late 10-K filing; has until June 3 to submit plan","bullets":["Failed to file Annual Report on Form 10-K for FY2023 ended Dec 31, 2023.","Received notice from Nasdaq on April 4, 2024; listing not immediately affected.","Must submit compliance plan by June 3, 2024; if accepted, exception may extend to Sept 30, 2024.","Failure to regain compliance could result in delisting of NBSE common stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-044287","json":"https://secwatch.observer/filing/0001104659-24-044287.json","markdown":"https://secwatch.observer/filing/0001104659-24-044287.md","text":"https://secwatch.observer/filing/0001104659-24-044287.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173281/000110465924044287/0001104659-24-044287-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173281/000110465924044287/tm2411211d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T01:41:11.548535+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"79670820ccb99f7e3f5c9618f1f7d62b5cc2cebf","claim":"NeuBase Therapeutics, Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"April 4, 2024, NeuBase Therapeutics, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with the continued listing requirements under the Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of the Company’s failure to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”) in a timely manner. The Rule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commiss","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1173281/000110465924044287/0001104659-24-044287-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"noncompliance notice"},{"label":"Deficiency","value":"late filing"},{"label":"Rules","value":"5250(c)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}